He noted that the final daily dose of liraglutide in the IDegLira group averaged 1.4 mg, compared with 1.8 mg in patients randomized to GLP-1 agonist monotherapy
long-term safety data is absent
Additionally, 85%, 89%, and 91% of participants in the 5 mg, 10 mg, and 15 mg tirzepatide groups, respectively, achieved a 5% or more weight reduction, while only 35% of those on placebo did
doi: 10.1007/s10875-020-00920-5 58 ShahbazSXuLOsmanMSliglWShieldsJJoyceMet al
I had very high cholesterol for years, along with cold hands and feet, dry skin, and a very low resting metabolic rate whenever I had it tested
Rhonda Patrick: I don't have a red light in my sauna